Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 3, 2020

Primary Completion Date

October 6, 2023

Study Completion Date

April 6, 2024

Conditions
Hiv
Interventions
BEHAVIORAL

Case Management

Each tier will have a different level of case management and support, all with the goal of increasing adherence to Biktarvy for HIV management.

Trial Locations (1)

60612

Ruth M. Rothstein CORE Center, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

Gregory Huhn

OTHER